The Registrar of Medical Schemes applied to place Medshield Medical Scheme (the fourth largest medical scheme in South Africa with approximately 207,000 beneficiaries) under curatorship. The application was brought in terms of s 56 of the Medical Schemes Act 131 of 1998 and s 5(1) and (2) of the Financial Institutions (Protection of Funds) Act 28 of 2001. The Registrar raised concerns about material irregularities in the scheme's governance, including: (1) unlawful broker management agreements with Medshield Broker (Pty) Ltd that contravened s 65(6) of the MS Act by compensating brokers indirectly; (2) improper payment of approximately R28 million in 'research fees' to brokers via intermediaries, exceeding prescribed maximum fees; (3) appointment of the BOT chairperson who was not a member at the time of election, contravening scheme rules; (4) appointment of the BOT chairperson as CEO, creating incompatible dual roles; (5) contracts with MDS and then Sapling (valued at R132 million over three years) for distribution services of questionable value; (6) orchestrated election of five trustees in June 2012 using proxies controlled by Sapling representatives, who joined the scheme only shortly before the election; (7) Sapling's indemnification of trustees' legal costs; and (8) the BOT's confrontational stance and refusal to comply with regulatory requirements. The North Gauteng High Court granted a final order of curatorship, which the trustees appealed.